I Mab Stock Z Score

IMAB Stock

USD 1.07 0.03 2.73%

Altman Z Score is one of the simplest fundamental models to determine how likely your company is to fail. The module uses available fundamental data of a given equity to approximate the Altman Z score. Altman Z Score is determined by evaluating five fundamental price points available from the company's current public disclosure documents. Check out I Mab Piotroski F Score and I Mab Valuation analysis.

For information on how to trade IMAB Stock refer to our How to Trade IMAB Stock guide.

At present, I Mab's Capital Surpluse is projected to increase significantly based on the last few years of reporting. The current year's Net Working Capital is expected to grow to about 2.6 B, whereas Capital Lease Obligations is forecasted to decline to about 37.9 M. At present, I Mab's Net Interest Income is projected to increase significantly based on the last few years of reporting. The current year's Interest Income is expected to grow to about 62.5 M, whereas Tax Provision is forecasted to decline to 0.00.

I Mab Company Z Score Analysis

I Mab's Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..

Z Score

Sum Of

5 Factors

More About Z Score | All Equity Analysis

First Factor

1.2 * (

Working Capital

/

Total Assets )

Second Factor

1.4 * (

Retained Earnings

/

Total Assets )

Thrid Factor

3.3 * (

EBITAD

/

Total Assets )

Fouth Factor

0.6 * (

Market Value of Equity

/

Total Liabilities )

Fifth Factor

0.99 * (

Revenue

/

Total Assets )

IMAB Z Score Driver Correlations

Understanding the fundamental principles of building solid financial models for I Mab is extremely important. It helps to project a fair market value of IMAB Stock properly, considering its historical fundamentals such as Z Score. Since I Mab's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of I Mab's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of I Mab's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Long Term Debt	Net Receivables	Good Will	Short Term Investments	Long Term Debt Total	Capital Surpluse	Total Liab	Net Invested Capital	Short Long Term Debt	Total Current Assets	Net Working Capital	Short Term Debt	Intangible Assets	Common Stock	Property Plant Equipment	Capital Stock
Total Assets		0.92	0.83	-0.68	-0.98	-0.56	-0.43	-0.81	0.7	-0.18	0.04	-0.77	0.75	-0.26	0.91	-0.88	1.0	1.0	-0.87	-0.41	0.87	0.61	0.8
Total Stockholder Equity	0.92		0.89	-0.56	-0.9	-0.53	-0.52	-0.62	0.62	-0.23	0.1	-0.55	0.66	-0.61	1.0	-0.78	0.92	0.93	-0.81	-0.43	0.87	0.59	0.84
Net Tangible Assets	0.83	0.89		-0.75	-0.82	-0.82	-0.74	-0.75	0.35	-0.6	-0.18	-0.68	0.82	-0.59	0.89	-0.85	0.85	0.85	-0.9	-0.78	0.68	0.84	0.96
Current Deferred Revenue	-0.68	-0.56	-0.75		0.68	0.88	0.73	0.89	-0.4	0.68	0.29	0.88	-0.96	0.05	-0.54	0.89	-0.71	-0.68	0.86	0.8	-0.43	-0.87	-0.83
Net Debt	-0.98	-0.9	-0.82	0.68		0.59	0.45	0.84	-0.62	0.21	0.06	0.81	-0.76	0.22	-0.89	0.91	-0.99	-0.98	0.9	0.41	-0.87	-0.59	-0.82
Retained Earnings	-0.56	-0.53	-0.82	0.88	0.59		0.82	0.82	-0.1	0.79	0.34	0.79	-0.87	0.25	-0.52	0.83	-0.6	-0.58	0.8	0.9	-0.4	-0.96	-0.89
Accounts Payable	-0.43	-0.52	-0.74	0.73	0.45	0.82		0.52	-0.04	0.63	0.36	0.46	-0.83	0.48	-0.52	0.69	-0.45	-0.42	0.68	0.73	-0.4	-0.79	-0.77
Long Term Debt	-0.81	-0.62	-0.75	0.89	0.84	0.82	0.52		-0.41	0.52	0.27	0.99	-0.87	-0.07	-0.61	0.94	-0.84	-0.81	0.9	0.66	-0.58	-0.78	-0.83
Net Receivables	0.7	0.62	0.35	-0.4	-0.62	-0.1	-0.04	-0.41		0.2	0.58	-0.39	0.38	-0.07	0.62	-0.51	0.68	0.68	-0.38	0.05	0.68	0.23	0.38
Good Will	-0.18	-0.23	-0.6	0.68	0.21	0.79	0.63	0.52	0.2		0.53	0.5	-0.58	0.29	-0.23	0.48	-0.23	-0.22	0.56	0.94	0.11	-0.72	-0.65
Short Term Investments	0.04	0.1	-0.18	0.29	0.06	0.34	0.36	0.27	0.58	0.53		0.29	-0.34	-0.11	0.11	0.19	0.02	0.04	0.39	0.48	0.3	-0.13	-0.16
Long Term Debt Total	-0.77	-0.55	-0.68	0.88	0.81	0.79	0.46	0.99	-0.39	0.5	0.29		-0.85	-0.17	-0.53	0.91	-0.8	-0.77	0.86	0.63	-0.53	-0.75	-0.77
Capital Surpluse	0.75	0.66	0.82	-0.96	-0.76	-0.87	-0.83	-0.87	0.38	-0.58	-0.34	-0.85		-0.15	0.65	-0.94	0.77	0.74	-0.91	-0.74	0.57	0.85	0.86
Total Liab	-0.26	-0.61	-0.59	0.05	0.22	0.25	0.48	-0.07	-0.07	0.29	-0.11	-0.17	-0.15		-0.62	0.17	-0.25	-0.29	0.26	0.34	-0.35	-0.3	-0.48
Net Invested Capital	0.91	1.0	0.89	-0.54	-0.89	-0.52	-0.52	-0.61	0.62	-0.23	0.11	-0.53	0.65	-0.62		-0.77	0.91	0.93	-0.8	-0.43	0.87	0.58	0.83
Short Long Term Debt	-0.88	-0.78	-0.85	0.89	0.91	0.83	0.69	0.94	-0.51	0.48	0.19	0.91	-0.94	0.17	-0.77		-0.9	-0.88	0.94	0.63	-0.75	-0.81	-0.92
Total Current Assets	1.0	0.92	0.85	-0.71	-0.99	-0.6	-0.45	-0.84	0.68	-0.23	0.02	-0.8	0.77	-0.25	0.91	-0.9		1.0	-0.89	-0.44	0.87	0.64	0.83
Net Working Capital	1.0	0.93	0.85	-0.68	-0.98	-0.58	-0.42	-0.81	0.68	-0.22	0.04	-0.77	0.74	-0.29	0.93	-0.88	1.0		-0.88	-0.43	0.86	0.62	0.82
Short Term Debt	-0.87	-0.81	-0.9	0.86	0.9	0.8	0.68	0.9	-0.38	0.56	0.39	0.86	-0.91	0.26	-0.8	0.94	-0.89	-0.88		0.72	-0.64	-0.75	-0.9
Intangible Assets	-0.41	-0.43	-0.78	0.8	0.41	0.9	0.73	0.66	0.05	0.94	0.48	0.63	-0.74	0.34	-0.43	0.63	-0.44	-0.43	0.72		-0.11	-0.86	-0.77
Common Stock	0.87	0.87	0.68	-0.43	-0.87	-0.4	-0.4	-0.58	0.68	0.11	0.3	-0.53	0.57	-0.35	0.87	-0.75	0.87	0.86	-0.64	-0.11		0.47	0.69
Property Plant Equipment	0.61	0.59	0.84	-0.87	-0.59	-0.96	-0.79	-0.78	0.23	-0.72	-0.13	-0.75	0.85	-0.3	0.58	-0.81	0.64	0.62	-0.75	-0.86	0.47		0.89
Capital Stock	0.8	0.84	0.96	-0.83	-0.82	-0.89	-0.77	-0.83	0.38	-0.65	-0.16	-0.77	0.86	-0.48	0.83	-0.92	0.83	0.82	-0.9	-0.77	0.69	0.89

Click cells to compare fundamentals

To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.

Competition

Predict I Mab

According to the company's disclosures, I Mab has a Z Score of 0.0. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The z score for all United States stocks is 100.0% higher than that of the company.

IMAB Z Score Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses I Mab's direct or indirect competition against its Z Score to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of I Mab could also be used in its relative valuation, which is a method of valuing I Mab by comparing valuation metrics of similar companies.

I Mab is currently under evaluation in z score category among its peers.

I Mab Current Valuation Drivers

We derive many important indicators used in calculating different scores of I Mab from analyzing I Mab's financial statements. These drivers represent accounts that assess I Mab's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of I Mab's important valuation drivers and their relationship over time.

	2020	2021	2022	2023	2024	2025 (projected)
Market Cap	21.0B	22.9B	2.4B	1.1B	1.0B	959.2M
Enterprise Value	16.3B	19.4B	(760.1M)	838.6M	754.8M	717.0M

I Mab Institutional Holders

Institutional Holdings refers to the ownership stake in I Mab that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of I Mab's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing I Mab's value.

		Shares
Renaissance Technologies Corp	2024-09-30	63.8 K
Dimensional Fund Advisors, Inc.	2024-09-30	58.4 K
Xtx Topco Ltd	2024-09-30	43 K
Mariner Wealth Advisors Llc	2024-09-30	31.5 K
Morgan Stanley - Brokerage Accounts	2024-09-30	30.6 K
Barclays Plc	2024-09-30	30.4 K
Geode Capital Management, Llc	2024-09-30	22 K
Susquehanna International Group, Llp	2024-09-30	13.4 K
Millennium Management Llc	2024-09-30	11.3 K
Hillhouse Capital Advisors, Ltd.	2024-09-30	6.9 M
Caligan Partners Lp	2024-09-30	3.5 M

IMAB Fundamentals

	Return On Equity	-0.72
	Return On Asset	-0.29
	Operating Margin	(49.38) %
	Current Valuation	(90.96 M)
	Shares Outstanding	77.58 M
	Shares Owned By Insiders	11.16 %
	Shares Owned By Institutions	31.00 %
	Number Of Shares Shorted	904 K
	Price To Book	0.41 X
	Price To Sales	24.97 X
	Revenue	27.64 M
	Gross Profit	41.59 M
	EBITDA	(1.21 B)
	Net Income	(206.77 M)
	Cash And Equivalents	3.92 B
	Cash Per Share	47.20 X
	Total Debt	18.89 M
	Debt To Equity	0.03 %
	Current Ratio	7.31 X
	Book Value Per Share	2.91 X
	Cash Flow From Operations	(1.3 B)
	Short Ratio	1.10 X
	Earnings Per Share	(2.16) X
	Price To Earnings To Growth	4.35 X
	Target Price	6.75
	Number Of Employees	34
	Beta	1.08
	Market Capitalization	85.74 M
	Total Asset	2.61 B
	Retained Earnings	(8.33 B)
	Working Capital	1.92 B
	Current Asset	1.51 B
	Current Liabilities	527.75 M
	Net Asset	2.61 B

About I Mab Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze I Mab's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of I Mab using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of I Mab based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

BTC	Bitcoin
TRX	TRON
BNB	Binance Coin

When determining whether I Mab offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of I Mab's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of I Mab Stock. Outlined below are crucial reports that will aid in making a well-informed decision on I Mab Stock:

How To Invest In IMAB

Details

Is IMAB Stock a good investment?

Details

What is I Mab's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out I Mab Piotroski F Score and I Mab Valuation analysis.

For information on how to trade IMAB Stock refer to our How to Trade IMAB Stock guide.

You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of I Mab. If investors know IMAB will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about I Mab listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(2.16)

Revenue Per Share

0.043

Quarterly Revenue Growth

(0.62)

Return On Assets

(0.29)

Return On Equity

(0.72)

The market value of I Mab is measured differently than its book value, which is the value of IMAB that is recorded on the company's balance sheet. Investors also form their own opinion of I Mab's value that differs from its market value or its book value, called intrinsic value, which is I Mab's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because I Mab's market value can be influenced by many factors that don't directly affect I Mab's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between I Mab's value and its price as these two are different measures arrived at by different means. Investors typically determine if I Mab is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, I Mab's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

I Mab Stock Z Score

I Mab Company Z Score Analysis

Z Score

Sum Of

5 Factors

First Factor

1.2 * (

Working Capital

/

Total Assets )

Second Factor

1.4 * (

Retained Earnings

/

Total Assets )

Thrid Factor

3.3 * (

EBITAD

/

Total Assets )

Fouth Factor

0.6 * (

Market Value of Equity

/

Total Liabilities )

Fifth Factor

0.99 * (

Revenue

/

Total Assets )

IMAB Z Score Driver Correlations

IMAB Z Score Peer Comparison

I Mab Current Valuation Drivers

I Mab Institutional Holders

IMAB Fundamentals

About I Mab Fundamental Analysis

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY